Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0L6OY
|
|||
| Former ID |
DIB012607
|
|||
| Drug Name |
GSK-2590066A
|
|||
| Synonyms |
Cell culture based influenza vaccines, Chemo-Sero-Therapeutic Research Institute/ GlaxoSmithKline
Click to Show/Hide
|
|||
| Indication | Influenza virus infection [ICD-11: 1E30-1E32] | Phase 1 | [1] | |
| Company |
GlaxoSmithKline plc
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01236040) Immunogenicity and Safety of Pandemic Influenza Vaccines in Adults Aged 18 - 49 Years Old. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.